419 related articles for article (PubMed ID: 37173951)
1. The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy.
Standing D; Feess E; Kodiyalam S; Kuehn M; Hamel Z; Johnson J; Thomas SM; Anant S
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173951
[TBL] [Abstract][Full Text] [Related]
2. Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer.
Ebersbach C; Beier AK; Thomas C; Erb HHH
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638338
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
Chen BY; Ye DF; Xie X; Chen HZ; Lü WG
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
Cheng M; Liu Y; Guo Y; Li M; Xian S; Qin H; Yang Y; Qian W; Tang J; Lu Y; Yao Y; Zhang M; Jin M; Xu L; Huang R; Xu D
Front Genet; 2023; 14():1120500. PubMed ID: 36968603
[No Abstract] [Full Text] [Related]
5. Interactions of the Nipah Virus P, V, and W Proteins across the STAT Family of Transcription Factors.
Keiffer TR; Ciancanelli MJ; Edwards MR; Basler CF
mSphere; 2020 Dec; 5(6):. PubMed ID: 33328346
[TBL] [Abstract][Full Text] [Related]
6. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
[TBL] [Abstract][Full Text] [Related]
7. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
[TBL] [Abstract][Full Text] [Related]
8. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.
Szelag M; Piaszyk-Borychowska A; Plens-Galaska M; Wesoly J; Bluyssen HA
Oncotarget; 2016 Jul; 7(30):48788-48812. PubMed ID: 27166190
[TBL] [Abstract][Full Text] [Related]
9. Toward a new STATe: the role of STATs in mitochondrial function.
Meier JA; Larner AC
Semin Immunol; 2014 Feb; 26(1):20-8. PubMed ID: 24434063
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies.
Rah B; Rather RA; Bhat GR; Baba AB; Mushtaq I; Farooq M; Yousuf T; Dar SB; Parveen S; Hassan R; Mohammad F; Qassim I; Bhat A; Ali S; Zargar MH; Afroze D
Front Pharmacol; 2022; 13():821344. PubMed ID: 35401182
[TBL] [Abstract][Full Text] [Related]
11. The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors.
Baci D; Bosi A; Gallazzi M; Rizzi M; Noonan DM; Poggi A; Bruno A; Mortara L
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354198
[TBL] [Abstract][Full Text] [Related]
12. Prognostic roles of signal transducers and activators of transcription family in human breast cancer.
Wang S; Yu L; Shi W; Li X; Yu L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29326301
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
Alunno A; Padjen I; Fanouriakis A; Boumpas DT
Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
[TBL] [Abstract][Full Text] [Related]
14. A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment.
Zhou M; Zhang P; Da M; Yang R; Ma Y; Zhao J; Ma T; Xia J; Shen G; Chen Y; Chen D
Front Oncol; 2022; 12():925537. PubMed ID: 36176415
[TBL] [Abstract][Full Text] [Related]
15. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
16. Balancing STAT Activity as a Therapeutic Strategy.
Polak KL; Chernosky NM; Smigiel JM; Tamagno I; Jackson MW
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684144
[TBL] [Abstract][Full Text] [Related]
17. STAT proteins: from normal control of cellular events to tumorigenesis.
Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
[TBL] [Abstract][Full Text] [Related]
18. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
19. The Dynamic Interface of Viruses with STATs.
Harrison AR; Moseley GW
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847860
[TBL] [Abstract][Full Text] [Related]
20. STATs in Lung Development: Distinct Early and Late Expression, Growth Modulation and Signaling Dysregulation in Congenital Diaphragmatic Hernia.
Piairo P; Moura RS; Baptista MJ; Correia-Pinto J; Nogueira-Silva C
Cell Physiol Biochem; 2018; 45(1):1-14. PubMed ID: 29310117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]